olfactory receptor family 10 subfamily AE member 3 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR10AE3P profile across patient tissues and cancer cell-line models. OR10AE3P expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, OR10AE3P is differentially expressed in 2, with the highest sampling consensus in KIRP. Additionally, OR10AE3P RNA expression shows 6,144 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight ACC, KIRP, and STAD as cancer lineages where OR10AE3P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR10AE3P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR10AE3P survival associations across molecular data types. OR10AE3P RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR10AE3P RNA expression–survival associations across cancer types. High OR10AE3P expression shows unfavorable associations in ACC, LIHC, UVM, LUAD, DLBC and KIRC. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for OR10AE3P RNA expression.
This table summarizes OR10AE3P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for OR10AE3P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR10AE3P shows higher tumor expression in KIRP and LIHC. The KIRP box plot shows higher OR10AE3P RNA expression in tumor versus normal tissue (log2 FC = +0.097, t-test p = .006).
This table shows molecular features associated with OR10AE3P in patient tissues and cancer cell lines. In patient samples, OR10AE3P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
